Ewa Paliczka-Cieślik

Statistics

Publications

Citations

207

H-Index

Active since

2009

Affiliations

The Maria Sklodowska-Curie National Research Institute of Oncology(Current)

Ewa Paliczka-Cieślik is an author at The Maria Sklodowska-Curie National Research Institute of Oncology specializing in medicine, oncology, and thyroid cancer.

ORCID

Publications per year

2009–2022

Publications

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Aleksandra Kukulska, Jolanta Krajewska, Marzena Gawkowska‐Suwińska et al. · Thyroid Research · 2010 · 64 citations · Full text

Medicine, Nuclear Medicine, Surgery +16

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

Daria Handkiewicz-Junak, Józef Roskosz, Kornelia Hasse-Lazar et al. · Thyroid Research · 2009 · 57 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

Dagmara Rusinek, Aleksandra Pfeifer, Marta Cieślicka et al. · Cancers · 2020 · 28 citations · Full text

Medicine, Genetics, Oncology +17

Managing tyrosine kinase inhibitors side effects in thyroid cancer

Jolanta Krajewska, Ewa Paliczka-Cieślik, Barbara Jarząb · Expert Review of Endocrinology & Metabolism · 2017 · 16 citations

Medicine, Oncology, Pharmacology +14

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

Jolanta Krajewska, Michał Jarząb, Aleksandra Kukulska et al. · Nuclear Medicine and Molecular Imaging · 2019 · 15 citations · Full text

Medicine, Oncology, Surgery +13

1–5 of 7